Tata India Pharma & Healthcare Fund Regular Growth
You have to be logged in to add this to Watchlist.
- Rating N.A.
- Plan
- 5D
- 1M
- 6M
- 1Y
- 5Y
- MAX
Key Metrics
- AUM (in Cr)899.17
- CAGR 46.86%
- Exit Load0.25%
- Expense ratio2.25%
- CategoryEquity
- Min Investment5000
- Min SIP100
- Launch Date2015-12-28
Asset Allocation
Holdings As On - 10 July 2024
- Name
- Value (Cr)
- Holding %
- Sun Pharmaceutical Industries
- 117.42
- 13.06%
- Aurobindo Pharma
- 87.87
- 9.77%
- Lupin
- 80.75
- 8.98%
- Dr Reddys Laboratories
- 62.35
- 6.93%
- Cipla
- 60.06
- 6.68%
- Zydus Lifesciences
- 47.14
- 5.24%
- Divis Laboratories
- 45.22
- 5.03%
- Fortis Healthcare
- 40.63
- 4.52%
- Alkem Laboratories
- 36.20
- 4.03%
- Apollo Hospitals Enterprise
- 34.40
- 3.83%
Peer Comparison
Risk & Volitility
- Alpha 11.23%
- Beta 0.70
- Sharpe Ratio0.66
- Std Deviation 14.23%
- Tracking Error 10.07%
About Fund
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 899.17 crores & has delivered CAGR of 25.95% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 2.25%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The top holdings of the fund include Sun Pharmaceutical Industries, Aurobindo Pharma, Lupin & Dr Reddys Laboratories.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Investment Services.
Some of the similar funds are Mirae Asset Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, UTI Healthcare Fund Regular Plan Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.66 & a standard deviation of 14.23%.
